Roche Media 9 janv. 2026 Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com
Roche Media 9 janv. 2026 Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News
FierceBiotech 9 janv. 2026 Roche returns to MediLink with promise of $570M near-term payments for another ADC
Roche Media 9 janv. 2026 Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech
Endpoints News 8 janv. 2026 Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
Endpoints News 8 janv. 2026 Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C
Endpoints News 8 janv. 2026 Former Genentech leaders’ protein degrader startup EpiBiologics nets $107M
Roche Media 6 janv. 2026 In Structure licensing deal, Roche commits $100M to shore up GLP-1 position - Fierce Biotech
Roche Media 6 janv. 2026 Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace
Roche Media 26 déc. 2025 Emerson and Roche Collaborate on Digital Modality Library for Pharmaceutical Development - Automation World
Roche Media 22 déc. 2025 Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues
Roche Media 22 déc. 2025 ROG.SW News Today: Trump Drug Plan Boosts Roche Stock on December 22 - Meyka
Roche Media 11 déc. 2025 Roche hails giredestrant effect in ER-positive early-stage breast cancer - The Pharma Letter